Source: BioPharma-Reporter

Mekonos: Mekonos announces research collaboration with Bit.Bio to advance cell engineering

Mekonos, a biotech platform developing cell therapies, has announced a new research collaboration with bit.bio, a synthetic biology company providing human cells for research, drug discovery and cell therapy.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Anil Narasimha's photo - Co-Founder & CEO of Mekonos

Co-Founder & CEO

Anil Narasimha

CEO Approval Rating

90/100

Read more